Pharmaceutical giant Johnson & Johnson may have known years ago about the deadly risks of its birth control patch Ortho Evra, according to internal documents obtained by NBC News. Patient reports ...
December 9, 2011 — Voting in favor of the norelgestromin/ethinyl estradiol transdermal contraceptive patch (Ortho Evra, Jannsen), a US Food and Drug Administration (FDA) advisory panel today ...
ADELPHI, Maryland (Reuters) - Drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch should be simplified to better explain the risk of blood clots. Advisers ...
Johnson & Johnson misled doctors and regulators for years by altering and withholding medical data about the health risks of its Ortho Evra birth-control patch, lawyers for women suing the company ...
WASHINGTON, Jan 18 (Reuters) - The label for a Johnson & Johnson contraceptive patch will include new data from a second study showing a higher risk of blood clots compared with birth-control pills, U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results